MedTech News
.................... by Andrew Celentano
United Therapeutics gets FDA green light for lung perfusion device
United Therapeutics (Nasdaq:UTHR) announced today that the FDA granted premarket approval (PMA) for its LungFX perfusion device.
Bioness wins FDA clearance for portable neurostimulator for stroke recovery
Bioness Medical announced today that it received FDA 510(k) clearance for its PoNS (portable neuromodulation stimulator) system.
Scientists uncover how ovarian cancer resists chemotherapy—and how to reverse it
Michigan State University researchers have identified how ovarian cancer cells become resistant to chemotherapy and discovered a protein that, when blocked, can restore the drug’s effectiveness.
4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia
MELBOURNE, Australia, June 29, 2026 /PRNewswire/ — 4DMedical Limited (ASX: 4DX), the global leader in advanced respiratory imaging, today announced that CT:VQ™ technology has Therapeutic Goods Administration (TGA) approval and is included on the Australian Register of Therapeutic Goods (ARTG)—enabling commercial deployment across Australia.
Valgen earns CE mark for mitral valve repair system
Valgen Medtech announced today that it received CE mark approval for its DragonFly transcathteter mitral repair system.
A 13-second eye test may help predict recovery of consciousness after severe brain injury
A simple bedside eye test may help predict recovery of consciousness in patients with severe brain injuries, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.
Hospital AI tool predicts low blood sugar in patients up to 24 hours in advance
Cedars-Sinai Health Sciences University investigators developed an AI-based model that can identify hospitalized patients at risk of low blood sugar up to 24 hours before the condition occurs
VR combined with nerve stimulation improves arm and hand function following a stroke
Researchers at the Medical University of Vienna and ETH Zurich have developed a rehabilitation platform for people suffering from the long-term effects of a stroke that combines virtual reality with targeted sensory nerve stimulation.